What did @midlifeinvintage actually say?
The creator described a specific, distressing symptom: her vulvar skin was tearing like "paper cuts" during perimenopause, particularly during her period. She tried thrush cream with no improvement. She started HRT in June, this episode happened in September, and she reports the problem has not returned in two years. She is careful to say she is "not a doctor" and frames it as correlation, not causation. That kind of epistemic honesty is rarer than it should be in this content category.
She is describing what clinicians would recognize as genitourinary syndrome of menopause, or GSM. The skin fragility, soreness, and tearing she describes are textbook GSM presentation. She never uses that term, which is fine, but it is worth naming it because millions of people experiencing exactly this have no idea there is a clinical name for it, let alone treatment options.
Does the science back this up?
Yes, substantially. The link between declining estrogen and vulvovaginal atrophy is one of the better-supported mechanisms in menopause medicine. The evidence for HRT improving GSM symptoms is solid, not just plausible.
The REVIVE survey (Nappi et al., 2016, Climacteric) found that 70% of postmenopausal women with GSM reported symptoms interfering with daily life, and tissue fragility causing micro-tears is a documented feature. Estrogen deficiency reduces collagen synthesis in vulvovaginal tissue and thins the epithelium, making it prone to fissuring with minimal friction. Systemic estrogen via HRT restores epithelial thickness over weeks to months. A Cochrane review (Lethaby et al., 2016) confirmed that both systemic and local estrogen significantly improve vaginal dryness, irritation, and soreness versus placebo. The two-year symptom resolution she describes is biologically plausible and consistent with what the literature shows for sustained HRT use.
What did they get wrong (or right)?
Mostly right, with one gap worth flagging. She correctly avoids claiming HRT cured her, framing it as correlation. That is genuinely responsible. The science does support her experience as the likely explanation, but there is a nuance she misses: systemic HRT alone is not always sufficient for GSM. Studies including Pinkerton et al. (2017, Menopause) suggest that local vaginal estrogen, used alongside or independently of systemic HRT, often produces faster and more targeted vulvovaginal tissue recovery.
Her assumption that the cream she bought was thrush treatment is understandable, but the clinical reality is that vulvar tearing with no itch and no discharge is often not candidiasis at all. Misdiagnosis of GSM as thrush is extremely common in primary care, and this is a real problem that delays appropriate treatment. She touched on this implicitly by noting it did not "feel like thrush," which is a clinically useful observation she glossed over too quickly. That point deserves more airtime.
What should you actually know?
GSM is underdiagnosed and undertreated. It affects an estimated 50-60% of postmenopausal women but is reported to only about a quarter of healthcare providers (Nappi et al., 2016). Symptoms like vulvar tearing, burning, and dryness are not something you should normalize or manage indefinitely with OTC thrush cream.
Treatment options now include:
- Local vaginal estrogen (cream, pessary, ring), which has minimal systemic absorption and is generally considered safe even for those who cannot use systemic HRT
- Systemic HRT, which helps many women but may not fully resolve vulvovaginal symptoms on its own
- Ospemifene, an oral SERM approved for dyspareunia due to GSM
- Non-hormonal moisturizers and lubricants for symptom management, though these do not reverse tissue atrophy
If you have vulvar symptoms that are not responding to antifungals, please see a clinician before assuming it is thrush. Lichen sclerosus, contact dermatitis, and GSM all present similarly and require different treatment. Self-treating with thrush cream while something else is going on delays care.